SCHEMBL4054090

SCHEMBL4054090

CNC(=O)C[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8335909 0.79
SCHEMBL13314133 0.75
SCHEMBL961615 0.74
SCHEMBL15782173 0.74
SCHEMBL17898497 0.73 POLB (0.41)
SCHEMBL9547377 0.72
SCHEMBL19072070 0.72 MCL1 (0.45)
SCHEMBL4330761 0.72 ALDH1A1 (0.44)
SCHEMBL2441916 0.69
SCHEMBL6586160 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107098850-A A kind of method for synthesizing the piperidones of 1 methyl, 3 nitro, 4 phenyl 2,6 2 西安近代化学研究所 2017-08-29 CN claimed
CN-107098850-A A kind of method for synthesizing the piperidones of 1 methyl, 3 nitro, 4 phenyl 2,6 2 西安近代化学研究所 2017-08-29 CN disclosed
CN-107098850-A A kind of method for synthesizing the piperidones of 1 methyl, 3 nitro, 4 phenyl 2,6 2 西安近代化学研究所 2017-08-29 CN disclosed
US-20170233726-A1 Method for Making an Enriched Library VIPERGEN APS (DK) 2017-08-17 US disclosed
US-20160195532-A1 Targeted Covalent Probes and Inhibitors of Proteins Containing Redox-Sensitive Cysteines THE SCRIPPS RESEARCH INSTITUTE 2016-07-07 US disclosed
US-20130288929-A1 Method for Making an Enriched Library VIPERGEN (DK) 2013-10-31 US disclosed
CN-101462969-B Synthesis method of 1-methylamino-1-methoxy-2-nitroethylene FUJIAN SHENNA BIOENGINEERING CO LTD 2012-04-25 CN disclosed
US-7592332-B2 Cytokine inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-09-22 US disclosed
US-7592332-B2 Cytokine inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-09-22 US disclosed
US-7592332-B2 Cytokine inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-09-22 US disclosed
US-20070275946-A1 Cytokine Inhibitors AUNGST RONALD A 2007-11-29 US disclosed
US-20070275946-A1 Cytokine Inhibitors AUNGST RONALD A 2007-11-29 US disclosed
US-7285545-B2 N-Pyridyl-7-substituted-2-indolecarboxamides, e.g., 1-Methyl-7-[2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yloxy]-1H-indole-2-carboxylic acid (2-tert-butyl-5-methoxy-pyridin-4-yl)-amide; used to treat chronic inflammatory diseases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2007-10-23 US disclosed
US-7285545-B2 N-Pyridyl-7-substituted-2-indolecarboxamides, e.g., 1-Methyl-7-[2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yloxy]-1H-indole-2-carboxylic acid (2-tert-butyl-5-methoxy-pyridin-4-yl)-amide; used to treat chronic inflammatory diseases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2007-10-23 US disclosed
US-7285545-B2 N-Pyridyl-7-substituted-2-indolecarboxamides, e.g., 1-Methyl-7-[2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yloxy]-1H-indole-2-carboxylic acid (2-tert-butyl-5-methoxy-pyridin-4-yl)-amide; used to treat chronic inflammatory diseases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2007-10-23 US disclosed
EP-1745036-A2 CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2007-01-24 EP disclosed
WO-2005108387-A2 CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-11-17 WO disclosed
US-20050245536-A1 Cytokine inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-11-03 US disclosed
CN-86108424-A The synthetic method of nizatidine 1987-08-05 CN disclosed
EP-0230127-A1 Synthesis of nizatidine ELI LILLY AND COMPANY (US) 1987-07-29 EP disclosed